Riskpilot← Back to searchSign inGet full accessGuldhedskliniken AB
ABActiveOrg 5566838677Reutersgatan 2 AMedical specialists activities · NACE 8622Est. 200510-19 employees
Revenue 2025
SEK 39,1M
+6% vs 2024
EBITDA margin
17.4%
+6% vs 2024
Equity ratio
50.1%
Financial strength
Net profit 2025
SEK 4,1M
0% vs 2024
| Revenue | SEK 39,1M | +6% |
| EBITDA | SEK 6,8M | +6% |
| Net profit | SEK 4,1M | +0% |
| Total assets | SEK 13,3M | -10% |
| Equity | SEK 6,7M | -11% |
| Employees | — | — |
Legal name
Guldhedskliniken AB
Org number
5566838677
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
13 juli 2005
Share capital
SEK 100 000
Employees
10-19
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva ögonsjukvård, utbildning samt konsultverksamhet inom ögonkirurgi samt därmed förenlig verksamhet.
Address
Reutersgatan 2 A
Email
pe@guldhedskliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 35 448 | 39 293 | 40 074 | 36 794 | 39 077 |
| Staff expenses | — | −15 420 | −15 871 | −16 853 | −16 893 |
| EBITDA | 7 539 | 9 447 | 8 780 | 6 395 | 6 789 |
| Depreciation & amort. | −728 | −1 418 | −1 068 | −1 180 | −1 377 |
| EBIT | 6 811 | 8 029 | 7 711 | 5 215 | 5 412 |
| Net financials | — | 1 | 14 | 16 | 8 |
| Profit before tax | 6 810 | 8 030 | 7 725 | 5 231 | 5 249 |
| Tax | −1 424 | −1 694 | −1 591 | −1 090 | −1 110 |
| Net profit | 5 386 | 6 336 | 6 133 | 4 141 | 4 139 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 704 | 15 360 | 15 918 | 14 799 | 13 322 |
| Equity | 7 929 | 9 265 | 9 399 | 7 540 | 6 679 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 8 775 | 6 094 | 6 520 | 7 260 | 6 644 |
| Total debt | 8 775 | 6 094 | 6 520 | 7 260 | 6 644 |
EBITDA margin
17.4%
This company
15.8%
Market median
+10% vs market
20212025
Equity ratio
50.1%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
62.0%
This company
18.4%
Market median
+237% vs market
20212025
Net profit margin
10.6%
This company
8.1%
Market median
+31% vs market
20212025
Asset turnover
2.93×
This company
1.12×
Market median
+162% vs market
20212025
Debt / equity
0.99×
This company
0.62×
Market median
+60% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ML | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Movimientos AB
Guldhedskliniken AB Board members of Guldhedskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Madeleine Louise Bratt | Audit | 0 companies |
| David Estehghari | Deputy Board Member | 0 companies |
| Peyman Estehghari | Board of Directors | 0 companies |
| Daniel Estehghari | Deputy Board Member | 0 companies |
| Emilia Shirin Estehghari | Deputy Board Member | 0 companies |